Answer
The safety and efficacy of LysaKare in children under 18 years have not been established, and no data are available.
Sources for this answer
- LysaKare 25 g/25 g solution for infusionNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.2 Posology and method of administration · Version 6Document updated
Sources checked